tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Madrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)
PremiumThe FlyMadrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)
3d ago
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
Madrigal Pharmaceuticals Signs Global License Agreement
Premium
Company Announcements
Madrigal Pharmaceuticals Signs Global License Agreement
9d ago
Madrigal Pharmaceuticals secures $500M in senior secured credit
PremiumThe FlyMadrigal Pharmaceuticals secures $500M in senior secured credit
17d ago
Madrigal Pharmaceuticals rises 12.4%
Premium
The Fly
Madrigal Pharmaceuticals rises 12.4%
23d ago
Madrigal patent for Rezdiffra ‘significant win,’ says Piper Sandler
Premium
The Fly
Madrigal patent for Rezdiffra ‘significant win,’ says Piper Sandler
23d ago
Positive CHMP Opinion Boosts Madrigal Pharmaceuticals’ Prospects for Rezdiffra in EU Market
PremiumRatingsPositive CHMP Opinion Boosts Madrigal Pharmaceuticals’ Prospects for Rezdiffra in EU Market
2M ago
Madrigal Pharmaceuticals receives positive CHMP opinion for resmetirom
Premium
The Fly
Madrigal Pharmaceuticals receives positive CHMP opinion for resmetirom
2M ago
Short Report: Bears bite into Krispy Kreme after another weak earnings report
Premium
The Fly
Short Report: Bears bite into Krispy Kreme after another weak earnings report
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100